Coppell Advisory Solutions »

Oncocyte Corporation shares owned by Coppell Advisory Solutions

Quarter-by-quarter ownership of Oncocyte Corporation (OCX) shares owned by Coppell Advisory Solutions from 13F filings

Historical chart of Coppell Advisory Solutions investment in Oncocyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Oncocyte Corporation held by Coppell Advisory Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncocyte Corporation by Coppell Advisory Solutions

Quarter filed Position value Share count Share price at filing
2024-09-30 $29 10 2.90
2024-06-30 $30 10 3.00
2023-12-31 $25 10 2.50

More positions owned by Coppell Advisory Solutions

First Tr Exchange Traded Fd Vi Tcw Opportunis Etf Fixd (FIXD)
First Tr Exchange Traded Fd Iv First Tr Enh New Etf FTSM (FTSM)
Tesla Tsla (TSLA)
Kingsmen Resources Ord KNG (KNG)
Walmart WMT (WMT)
Oracle Corp Orcl (ORCL)
Unitedhealth Group Unh (UNH)
Spdr Series Trust Spdr Bloomberg Etf Bil (BIL)
First Tr Exchange Traded Fd Vi Ft Cboe Vest U S Eq Bufer S Bufr (BUFR)
SPDR S&P 500 ETF Trust Spy (SPY)
Etf Series Solutions Aam Lw Dur Pfd Etf PFLD (PFLD)
Ft Cboe Vest Fund Of Deep Buffer Etf Bufd (BUFD)
First Tst Value Li Shs Etf FVD (FVD)
Microsoft Corp MSFT (MSFT)
Apple Aapl (AAPL)

View all positions for Coppell Advisory Solutions

Top funds holding Oncocyte Corporation

AWM Investment Company
Vanguard Group
Geode Capital Management
BlackRock
Morgan Stanley
BlackRock
FNY Investment Advisers
State Street Corporation
Northern Trust
Tower Research Capital
Advisor Group Holdings
Bank of America Corporation
Jpmorgan Chase & Co
Piscataqua Savings Bank
Coppell Advisory Solutions

View all funds holding Oncocyte Corporation